Delivery Order SPE2DB22D2007-SPE2DB24FJ2BY

Award Date 5/1/24
Potential Completion Date 5/2/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,615.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a generic pharmaceutical product, to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,958.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567332061 - RIFAMPIN 300 MG CAPSULE 60S, a prescription medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,981.65 firm-fixed-price delivery order contract is for the supply of 4564885228 - RIFAMPIN 300 MG CAPSULE 60S. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,505.57 firm fixed-price delivery order is for RIFAMPIN 300 MG CAPSULE 30S, a generic pharmaceutical product, with a period of performance through February 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with a ceiling value of $1,499.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the procurement of 4563346523 - RIFAMPIN 300 MG CAPSULE 60S, with an ultimate completion date of January 18, 2024. The contract is a Firm Fixed Price (FFP) arrangement, and there is no set-aside designation mentioned. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,115.68 firm-fixed-price delivery order is for the supply of 4567037178 RIFAMPIN 300 MG CAPSULE 60S, with a completion date of January 27, 2025. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, with ID SPE2DB22D2009|SPE2DB25FL6EW, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,586.27 firm fixed-price contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a medical product, with a completion date of November 1, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award, with an ID of SPE2DB22D2007|SPE2DB25FH8XW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,127.57, is for the delivery of 4567220058 RIFAMPIN 300 MG CAPSULE 60S. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award, valued at $5,723.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a medical commodity, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $2,746.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product. The contract has an Ultimate Completion Date of July 19, 2024 and a Ceiling Value of $2,746.58. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen Drug Corp...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ2BY
    Delivery Order

This federal contract award, with ID SPE2DB22D2007|SPE2DB24FJ2BY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,134.87, is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product, to support federal healthcare programs.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive experience in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems, positions the company as a key vendor for this critical contract.

Generated 5/16/25, 11:48 AM